ARCHIVES

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

DeVita Defends CHP Awards, Says Program Has High Priority

September 5, 1980

Arthur Upton Will Be New NCI Director; Colleagues Convinced He’ll Be strong Leader

June 10, 1977

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

December 27, 2013

Funding Opportunity: Stand Up To Cancer Canada to Fund Two Dream Teams

October 17, 2014

NCI-Funded Modelers Accurately Predicted Outcome Of Lung Cancer Screening Trial

November 26, 2010